The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 (coronavirus disease 2019), which is associated with high morbidity and mortality, especially in elder patients. Acute respiratory distress syndrome (ARDS) is a life-threatening complication of COVID-19 and has been linked...

Descripción completa

Detalles Bibliográficos
Autores principales: Neubauer, Andreas, Johow, Johannes, Mack, Elisabeth, Burchert, Andreas, Meyn, Damaris, Kadlubiec, Andrea, Torje, Iuliu, Wulf, Hinnerk, Vogelmeier, Claus F., Hoyer, Joachim, Skevaki, Chrysanthi, Muellenbach, Ralf Michael, Keller, Christian, Schade-Brittinger, Carmen, Rolfes, Caroline, Wiesmann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358255/
https://www.ncbi.nlm.nih.gov/pubmed/34385593
http://dx.doi.org/10.1038/s41375-021-01374-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358255/
https://www.ncbi.nlm.nih.gov/pubmed/34385593
http://dx.doi.org/10.1038/s41375-021-01374-3

Ejemplares similares